89bio, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.

CEO

Rohan Palekar

CEORohan Palekar

Employees

Employees93

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2018

Founded2018

Employees

Employees93

ETNB Key Statistics

Market cap

1.01B

Market cap1.01B

Price-Earnings ratio

-2.01

Price-Earnings ratio-2.01

Dividend yield

—

Dividend yield—

Average volume

1.37M

Average volume1.37M

High today

$6.97

High today$6.97

Low today

$6.55

Low today$6.55

Open price

$6.61

Open price$6.61

Volume

882.92K

Volume882.92K

52 Week high

$11.84

52 Week high$11.84

52 Week low

$4.16

52 Week low$4.16

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell